INVO Competitors

Stocks . USA . 
Stock . INVO Fertility
IVF Stock   0.95  0.01  1.04%   
INVO Fertility competes with Thrivent High, Morningstar Unconstrained, Via Renewables, T Rowe, and Sitka Gold; as well as few others. The company runs under Health Care Equipment & Supplies sector within Health Care industry. Analyzing INVO Fertility competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of INVO Fertility to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out INVO Fertility Correlation with its peers.
For more detail on how to invest in INVO Stock please use our How to Invest in INVO Fertility guide.

INVO Fertility vs Sycamore Entmt Correlation

Average diversification

The correlation between INVO Fertility and SEGI is 0.19 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding INVO Fertility and SEGI in the same portfolio, assuming nothing else is changed.

Moving against INVO Stock

  0.35HYB HOYAPairCorr
  0.35DXCM DexCom IncPairCorr
The current Return On Tangible Assets is estimated to decrease to -1.79. The INVO Fertility's current Return On Capital Employed is estimated to increase to -0.31. At this time, INVO Fertility's Intangible Assets are most likely to increase significantly in the upcoming years. The INVO Fertility's current Intangibles To Total Assets is estimated to increase to 1.08, while Total Current Assets are projected to decrease to roughly 1.4 M.
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of INVO Fertility's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.040.7727.37
Details
Intrinsic
Valuation
LowRealHigh
0.091.7028.30
Details
Naive
Forecast
LowNextHigh
0.031.3527.95
Details
1 Analysts
Consensus
LowTargetHigh
3.644.004.44
Details

INVO Fertility Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between INVO Fertility and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of INVO and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of INVO Fertility does not affect the price movement of the other competitor.

High positive correlations

OSHDF
+ 1.0
ONCSQ
RRTLX
+ 0.96
MSTSX
RRTLX
+ 0.95
VIASP
VIASP
+ 0.91
MSTSX
RWAYL
+ 0.86
RRTLX
RRTLX
+ 0.85
LBHIX
  

High negative correlations

SEGI
- 0.67
VIASP
SEGI
- 0.62
RRTLX
SEGI
- 0.6
MSTSX
SEGI
- 0.59
RWAYL
SEGI
- 0.48
LBHIX
SITKF
- 0.32
VIASP

Risk-Adjusted Indicators

There is a big difference between INVO Stock performing well and INVO Fertility Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze INVO Fertility's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
ONCSQ  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
LBHIX  0.12  0.04 (0.35) 0.46  0.00 
(0.22)
 0.24 
(0.12)
 2.15 
MSTSX  0.62  0.28  0.29  8.99  0.00 
(0.77)
 1.45 
(0.88)
 12.34 
VIASP  0.28  0.05 (0.09) 10.66  0.17 
(0.33)
 0.64 
(0.59)
 1.72 
RRTLX  0.25  0.07  0.06  0.31  0.00 
(0.34)
 0.57 
(0.40)
 3.30 
WQTM  1.68  0.07  0.05  0.12  1.88 
(1.73)
 3.48 
(3.22)
 9.00 
OSHDF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
SITKF  2.67  0.20  0.06  0.28  2.79 
(3.55)
 7.81 
(5.71)
 16.83 
RWAYL  0.12  0.01 (0.40) 0.43  0.00 
(0.15)
 0.24 
(0.20)
 0.88 
SEGI  11.09  1.16  0.05  0.64  11.35 
(29.49)
 33.33 
(25.00)
 58.33 

INVO Fertility Competitive Analysis

The better you understand INVO Fertility competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, INVO Fertility's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across INVO Fertility's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
IVF ONCSQ LBHIX MSTSX VIASP RRTLX WQTM OSHDF SITKF RWAYL
 1.04 
 0.95 
INVO
 0.00 
 0.0001 
OncoSec
 0.17 
 17.17 
Thrivent
 0.53 
 11.47 
Morningstar
 0.47 
 25.73 
Via
 0.08 
 13.06 
RRTLX
 1.81 
 27.10 
WisdomTree
 0.00 
 0.04 
Oshidori
 2.53 
 0.81 
Sitka
 0.40 
 25.10 
MSCI
Market Volatility
(90 Days Market Risk)
Out of control
Very steady
Very steady
Not too volatile
Very steady
Very steady
Very steady
Very steady
Extremely Dangerous
Very steady
Market Performance
(90 Days Performance)
Weak
Weakest
Good
Good
Good
Solid
Soft
Weakest
Mild
Good
Odds of Financial Distress
(Probability Of Bankruptcy)
Risky
Unknown
Low
Low
Fair
Low
Fair
High
Moderate
Low
Current Valuation
(Equity Enterprise Value)
Under Valued
Over Valued
Over Valued
Fairly Valued
Under Valued
Fairly Valued
Fairly Valued
Over Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Hold
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Strong Sell
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Strong Sell
Strong Sell
Hold
Strong Buy
Sell
Hold
Strong Sell
Strong Sell
Strong Sell
Current Ratio
N/A
N/A
N/A
N/A
3.49
N/A
N/A
N/A
4.24
N/A
Net Asset
46.45 M
N/A
797.1 M
116.1 M
355.28 M
1.46 B
N/A
6.31 B
13.41 M
N/A
EBITDA
(7.14 M)
N/A
N/A
N/A
33.09 M
N/A
N/A
(3.49 B)
(1.57 M)
N/A
Operating Margin
-0.93
N/A
N/A
N/A
-0.14
N/A
N/A
1.04
N/A
N/A
Five Year Return
N/A
N/A
4.12
9.1
8.97
0.0406
N/A
N/A
N/A
N/A
One Year Return
N/A
N/A
7.75
15.47
N/A
0.067
N/A
N/A
N/A
N/A
Beta
N/A
N/A
N/A
N/A
1.16
N/A
N/A
0.67
1.45
N/A
Number Of Employees
33
N/A
1
1
169
1
N/A
31
1
N/A
Three Year Return
N/A
N/A
8.79
13.43
N/A
0.0491
N/A
N/A
N/A
N/A
Cash Flow From Operations
(2.97 M)
N/A
N/A
N/A
12.7 M
N/A
N/A
499.26 M
(1.27 M)
N/A
Total Debt
9.9 M
N/A
N/A
N/A
135 M
N/A
N/A
N/A
40 K
N/A
Bond Positions Weight
N/A
N/A
92.23
22.72
N/A
14.43
N/A
N/A
N/A
N/A
Holdings Turnover
N/A
N/A
N/A
269.0
N/A
N/A
N/A
N/A
N/A
N/A
Return On Asset
-0.48
N/A
N/A
N/A
-0.11
N/A
N/A
-0.46
-0.033
N/A
Current Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Short Ratio
0.02
N/A
N/A
N/A
0.7
N/A
N/A
N/A
N/A
N/A
Debt To Equity
N/A
N/A
N/A
N/A
0.69
N/A
N/A
N/A
0.002
N/A
Shares Owned By Institutions
9.43
N/A
N/A
N/A
N/A
N/A
N/A
0.84
10.92
N/A
Market Capitalization
6.67 M
N/A
N/A
50.36 M
N/A
N/A
N/A
233.49 M
12.62 M
N/A
Price To Earning
N/A
N/A
35.48
N/A
26.83
18.25
N/A
N/A
N/A
N/A
Price To Sales
0.96
N/A
1.23
N/A
N/A
1.57
N/A
N/A
N/A
N/A
Net Income
(9.1 M)
N/A
N/A
N/A
5.2 M
N/A
N/A
(3.15 B)
(1.28 M)
N/A
Shares Owned By Insiders
1.2
N/A
N/A
N/A
N/A
N/A
N/A
30.28
5.97
N/A
Revenue
6.53 M
N/A
N/A
N/A
393.49 M
N/A
N/A
(3.1 B)
N/A
N/A
Year To Date Return
N/A
N/A
1.0
3.92
N/A
-0.0211
N/A
N/A
N/A
N/A
Working Capital
(16.61 M)
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Profit Margin
N/A
N/A
N/A
N/A
0.0094
N/A
N/A
N/A
N/A
N/A
Current Valuation
20.35 M
N/A
N/A
N/A
535.95 M
N/A
N/A
103.84 M
8.05 M
N/A
Price To Book
5.97
N/A
1.58
N/A
N/A
2.13
N/A
0.005
1.1
N/A
Retained Earnings
(67.16 M)
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Asset
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash Position Weight
N/A
N/A
6.56
14.28
N/A
7.22
N/A
N/A
N/A
N/A
Equity Positions Weight
N/A
N/A
0.07
61.63
N/A
38.52
N/A
N/A
N/A
N/A
Shares Outstanding
6.96 M
N/A
N/A
N/A
N/A
N/A
N/A
6.11 B
159.12 M
N/A
Annual Yield
N/A
N/A
0.0619
0.0218
0.0972
0.0283
N/A
N/A
N/A
N/A
Return On Equity
N/A
N/A
N/A
N/A
0.017
N/A
N/A
-0.5
-0.0611
N/A
Z Score
N/A
N/A
N/A
N/A
1.0
N/A
N/A
N/A
N/A
N/A
Number Of Shares Shorted
284.6 K
N/A
N/A
N/A
4.29 K
N/A
N/A
N/A
N/A
2.19 K
Book Value Per Share
-4.47
N/A
N/A
N/A
3.66
N/A
N/A
0.89
0.1
N/A
Minimum Initial Investment
N/A
N/A
2 K
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Asset
46.45 M
N/A
491.38 M
215.11 M
355.28 M
1.03 B
N/A
6.31 B
13.41 M
N/A
Target Price
4.0
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Last Dividend Paid
N/A
N/A
0.02
N/A
0.73
0.14
N/A
N/A
N/A
N/A
Earnings Per Share
-294.88
N/A
N/A
N/A
1.17
N/A
N/A
N/A
-0.01
N/A
Ten Year Return
N/A
N/A
6.0
N/A
N/A
5.76
N/A
N/A
N/A
N/A
Cash And Equivalents
N/A
N/A
N/A
N/A
51.31 M
N/A
N/A
N/A
5.77 M
N/A
Cash Per Share
N/A
N/A
N/A
N/A
3.23
N/A
N/A
N/A
0.04
N/A
Gross Profit
2.72 M
N/A
N/A
N/A
74.67 M
N/A
N/A
(4.09 B)
N/A
N/A
Day Typical Price
0.94
1.0E-4
17.17
11.47
25.69
13.06
26.96
0.036
0.81
25.15
Accumulation Distribution
15030.57
N/A
N/A
N/A
4.66
N/A
368.58
N/A
1591.52
17.73
Market Facilitation Index
N/A
N/A
N/A
N/A
2.0E-4
N/A
0.0
N/A
N/A
1.0E-4
Daily Balance Of Power
(0.20)
0.0
0
9.2 T
0.8571
0
(1.11)
0.0
2.0
(0.45)
Period Momentum Indicator
(0.01)
N/A
(0.03)
0.06
0.12
(0.01)
(0.50)
N/A
0.02
(0.10)
Rate Of Daily Change
0.99
1.0
1.0
1.01
1.0
1.0
0.98
1.0
1.03
1.0
Day Median Price
0.94
1.0E-4
17.17
11.47
25.67
13.06
26.9
0.036
0.82
25.17
Price Action Indicator
0.01
N/A
(0.01)
0.03
0.12
(0.01)
(0.04)
N/A
0.005
(0.12)
Relative Strength Index
65.34
N/A
33.85
94.4
57.57
95.26
64.52
N/A
57.72
24.42
Coefficient Of Variation
10192.01
N/A
495.45
491.38
601.22
382.36
1089.77
N/A
1268.19
564.07
Mean Deviation
9.87
N/A
0.1245
0.6182
0.2839
0.2535
1.68
N/A
2.67
0.1172
Jensen Alpha
1.02
N/A
0.0358
0.2832
0.0497
0.0728
0.0655
N/A
0.1954
0.0143
Total Risk Alpha
(2.46)
N/A
0.0158
0.1341
0.0124
0.0548
(0.04)
N/A
(0.10)
0.0013
Sortino Ratio
0.0175
N/A
(0.35)
0.2891
(0.09)
0.0555
0.0508
N/A
0.0567
(0.40)
Downside Variance
88.44
N/A
0.0109
0.5071
0.1204
0.1043
4.15
N/A
11.77
0.0248
Standard Deviation
25.92
N/A
0.2642
1.45
0.3614
0.4123
2.11
N/A
3.61
0.1553
Kurtosis
48.22
N/A
39.22
43.98
(0.06)
17.44
(0.21)
N/A
1.4
1.2
Potential Upside
12.22
N/A
0.2413
1.45
0.6405
0.5728
3.48
N/A
7.81
0.2417
Treynor Ratio
(0.03)
N/A
0.4605
8.99
10.66
0.3122
0.1243
N/A
0.2774
0.4276
Maximum Drawdown
218.36
N/A
2.15
12.34
1.72
3.3
9.0
N/A
16.83
0.8772
Variance
671.62
N/A
0.0698
2.11
0.1306
0.17
4.44
N/A
13.01
0.0241
Market Risk Adjusted Performance
(0.02)
N/A
0.4705
9.0
10.67
0.3222
0.1343
N/A
0.2874
0.4376
Risk Adjusted Performance
0.0172
N/A
0.1355
0.1605
0.1161
0.1916
0.0766
N/A
0.0682
0.0964
Skewness
6.5
N/A
5.67
6.01
0.0374
2.97
0.25
N/A
0.6803
0.142
Semi Deviation
8.98
N/A
0.0
0.0
0.1667
0.0
1.88
N/A
2.79
0.0
Information Ratio
0.0063
N/A
(0.14)
0.1416
(0.08)
0.0435
0.0491
N/A
0.0539
(0.40)
Value At Risk
(15.19)
N/A
(0.12)
(0.88)
(0.59)
(0.40)
(3.22)
N/A
(5.71)
(0.20)
Expected Short fall
(18.36)
N/A
(0.22)
(0.77)
(0.33)
(0.34)
(1.73)
N/A
(3.55)
(0.15)
Downside Deviation
9.4
N/A
0.1044
0.7121
0.347
0.3229
2.04
N/A
3.43
0.1574
Semi Variance
80.65
N/A
(0.05)
(0.05)
0.0278
(0.06)
3.55
N/A
7.76
(0.01)

INVO Fertility Competition Performance Charts

Five steps to successful analysis of INVO Fertility Competition

INVO Fertility's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by INVO Fertility in relation to its competition. INVO Fertility's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of INVO Fertility in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact INVO Fertility's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to INVO Fertility, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your INVO Fertility position

In addition to having INVO Fertility in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Monster Funds Thematic Idea Now

Monster Funds
Monster Funds Theme
Solid funds with above average long term performance indicators based on Macroaxis rating system. The Monster Funds theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Monster Funds Theme or any other thematic opportunities.
View All  Next Launch
When determining whether INVO Fertility is a strong investment it is important to analyze INVO Fertility's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact INVO Fertility's future performance. For an informed investment choice regarding INVO Stock, refer to the following important reports:
How To Invest In INVO
Details
Is INVO Stock a good investment?
Details
What is INVO Fertility's Net Worth?
Details
Largest Health Care Equipment & Supplies Companies
View
Largest Health Care Equipment & Services Companies
View
Check out INVO Fertility Correlation with its peers.
For more detail on how to invest in INVO Stock please use our How to Invest in INVO Fertility guide.
You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Can Health Care Equipment & Supplies industry sustain growth momentum? Does INVO have expansion opportunities? Factors like these will boost the valuation of INVO Fertility. Market participants price INVO higher when confident in its future expansion prospects. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating INVO Fertility demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Earnings Share
(294.88)
Revenue Per Share
50.542
Quarterly Revenue Growth
0.226
Return On Assets
(0.48)
Understanding INVO Fertility requires distinguishing between market price and book value, where the latter reflects INVO's accounting equity. The concept of intrinsic value - what INVO Fertility's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Market sentiment, economic cycles, and investor behavior can push INVO Fertility's price substantially above or below its fundamental value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between INVO Fertility's value and its price as these two are different measures arrived at by different means. Investors typically determine if INVO Fertility is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, INVO Fertility's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY